Literature DB >> 2786359

Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS.

G R Mason1, C H Hashimoto, P S Dickman, L F Foutty, C J Cobb.   

Abstract

The clinical records and bronchoalveolar lavage (BAL) cell differential counts were analyzed in 96 patients at risk for Pneumocystis carinii pneumonia (PCP) from human immunodeficiency virus (HIV) infection to determine if this information may be prognostically useful and to identify possible mechanisms of BAL neutrophilia. In 60 patients with PCP, 15 fatalities or episodes of respiratory failure occurred, and 14 of these patients had greater than 5% BAL neutrophils. Only one of 33 patients with PCP and less than 5% BAL neutrophils died. In contrast, there was no correlation between survival and BAL neutrophil percentages in 33 patients who did not have PCP. Three patients with HIV infection without lung disease had normal BAL cell differentials. Intra-alveolar and interstitial leukocytes found in 17 transbronchial lung biopsies in patients with PCP indicate that the alveolar and interstitial compartments of the lung may be the source of BAL neutrophils. Pathologic evidence of increased severity of diffuse alveolar damage to explain BAL neutrophilia was not found. As BAL neutrophil percentages in PCP had both positive and negative predictive value, this information may be useful to stratify therapeutic trials or to identify the patient with PCP who is at high risk of a complicated or fatal outcome.

Entities:  

Mesh:

Year:  1989        PMID: 2786359     DOI: 10.1164/ajrccm/139.6.1336

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  30 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS.

Authors:  M J Gill; R Read
Journal:  Can J Infect Dis       Date:  1991

Review 3.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

4.  Pneumocystis carinii inhibits cyclin-dependent kinase activity in lung epithelial cells.

Authors:  A H Limper; M Edens; R A Anders; E B Leof
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms.

Authors:  Scott E Evans; Peter Y Hahn; Frances McCann; Theodore J Kottom; Zvezdana Vuk Pavlovic'; Andrew H Limper
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-03       Impact factor: 6.914

6.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

8.  The inhibitory effect of pentamidine on the production of chemotactic cytokines by in vitro stimulated human blood cells.

Authors:  J Van Wauwe; F Aerts; H Van Genechten; H Blockx; W Deleersnijder; H Walter
Journal:  Inflamm Res       Date:  1996-07       Impact factor: 4.575

9.  Pneumocystis cell wall beta-glucan stimulates calcium-dependent signaling of IL-8 secretion by human airway epithelial cells.

Authors:  Eva M Carmona; Jeffrey D Lamont; Ailing Xue; Mark Wylam; Andrew H Limper
Journal:  Respir Res       Date:  2010-07-13

10.  MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection.

Authors:  Sheila N Bello-Irizarry; Jing Wang; Carl J Johnston; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.